1. Silicone adhesive multilayer foam dressings to prevent hospital-acquired sacrum pressure ulcers: An economic evaluation based on a publicly funded pragmatic randomized controlled trial linked with real-world data.
- Author
-
Neyt M, De Meester C, Devriese S, Marynen E, and Beeckman D
- Subjects
- Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Adhesives, Belgium, Bandages economics, Bandages standards, Cost-Benefit Analysis methods, Cost-Benefit Analysis statistics & numerical data, Pressure Ulcer prevention & control, Pressure Ulcer economics, Sacrum, Silicones
- Abstract
Objectives: To estimate the cost-effectiveness of sacrum multilayer silicone foam dressings as an adjuvant prophylactic therapy compared to standard pressure ulcer prevention in a hospital population at high risk for pressure ulcer development., Methods: An economic evaluation is performed from a healthcare payer's perspective. This evaluation is based on a Belgian publicly funded pragmatic randomized controlled trial (RCT), linked with real-world data from administrative claims database and a Belgian cost analysis. A cost-consequences analysis with a one-year time horizon is performed., Results: The RCT has shown that the risk of developing a new pressure ulcer on the sacrum was statistically significantly reduced by 41 % in the treatment group (RR = 0.59, 95 % CI 0.35-0.98, p = 0.04). The absolute risk reduction of 2.0 % (95 % CI -0.1-4.1 %) coincides with a number needed to treat of 50.0 to prevent one new pressure ulcer of category II or worse. The evolution of quality of life is on average negative for patients who developed a pressure ulcer before day 3, while it is positive for patients without pressure ulcers. In a scenario with conservative assumptions, i.e. without inclusion of price discounts for the multilayer silicone foam dressings and only including costs during the hospitalization, pressure ulcer prevention with dressings on the sacrum was already cost-neutral., Conclusions: The preventive use of silicone adhesive multilayer foam dressings on the sacrum for a population similar to the pragmatic trial population can be supported both from a clinical and economic point of view., Competing Interests: Declaration of competing interest MN, CDM, SD and EM are members of the KCE Expert Team. KCE is a federal institution. KCE's mission is to advise policymakers on decisions relating to health care and health insurance on the basis of scientific and objective research. KCE has no interest in companies (commercial or non-commercial, i.e. hospitals and universities), associations (e.g. professional associations, unions), individuals or organisations (e.g. lobby groups) that could be positively or negatively affected (financially or in any other way) by the implementation of the recommendations. MN, CDM, SD and EM have no relevant interests to declare. DB has the following interests to declare: Membership of the European Pressure Ulcer Advisory Panel (EPUAP), European Wound Management Association (EWMA), and International Skin Tear Advisory Panel (ISTAP)). Participation in pressure ulcer research (investigator initiated) funded by industry developing prophylactic multi-layer foam dressings. Research grant provided by Mölnlycke Healthcare (Core Outcome Sets in clinical studies on bordered foam dressings). Member of International Wound Dressing Technology Expert Panel (IWDTEP) - Mölnlycke Healthcare. Fees for speaking at scientific meetings by companies in this sector (Mölnlycke Healthcare, Smith & NephewSmith & Nephew, 3M Healthcare, Flen Pharma)., (Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF